Literature DB >> 2182439

Dutch Childhood Leukemia Study Group: early results of study ALL VI (1984-1988).

A J Veerman1, K Hählen, W A Kamps, E F Vanleeuwen, G A de Vaan, E R Vanwering, A Vanderdoes-Vandenberg, G Solbu, S Suciu.   

Abstract

Entities:  

Mesh：

Year:  1990        PMID： 2182439     DOI： 10.1007/978-3-642-74643-7_85

Source DB:  PubMed          Journal:  Haematol Blood Transfus        ISSN： 0171-7111


× No keyword cloud information.
  4 in total

1.  Escalating intravenous methotrexate improves event-free survival in children with standard-risk acute lymphoblastic leukemia: a report from the Children's Oncology Group.

Authors:  Yousif Matloub; Bruce C Bostrom; Stephen P Hunger; Linda C Stork; Anne Angiolillo; Harland Sather; Mei La; Julie M Gastier-Foster; Nyla A Heerema; Scott Sailer; Patrick J Buckley; Blythe Thomson; Catherine Cole; James B Nachman; Gregory Reaman; Naomi Winick; William L Carroll; Meenakshi Devidas; Paul S Gaynon
Journal:  Blood       Date:  2011-05-11       Impact factor: 22.113

Review 2.  Cellular drug resistance in childhood leukemia.

Authors:  A J Veerman; G J Kaspers; R Pieters
Journal:  Ann Hematol       Date:  1994       Impact factor: 3.673

3.  Intrathecal triple therapy decreases central nervous system relapse but fails to improve event-free survival when compared with intrathecal methotrexate: results of the Children's Cancer Group (CCG) 1952 study for standard-risk acute lymphoblastic leukemia, reported by the Children's Oncology Group.

Authors:  Yousif Matloub; Susan Lindemulder; Paul S Gaynon; Harland Sather; Mei La; Emmett Broxson; Rochelle Yanofsky; Raymond Hutchinson; Nyla A Heerema; James Nachman; Marilyn Blake; Linda M Wells; April D Sorrell; Margaret Masterson; John F Kelleher; Linda C Stork
Journal:  Blood       Date:  2006-04-11       Impact factor: 22.113

4.  Dexamethasone (6 mg/m2/day) and prednisolone (60 mg/m2/day) were equally effective as induction therapy for childhood acute lymphoblastic leukemia in the EORTC CLG 58951 randomized trial.

Authors:  Carine Domenech; Stefan Suciu; Barbara De Moerloose; Françoise Mazingue; Geneviève Plat; Alina Ferster; Anne Uyttebroeck; Nicolas Sirvent; Patrick Lutz; Karima Yakouben; Martine Munzer; Pierre Röhrlich; Dominique Plantaz; Frederic Millot; Pierre Philippet; Nicole Dastugue; Sandrine Girard; Hélène Cavé; Yves Benoit; Yves Bertrandfor
Journal:  Haematologica       Date:  2014-04-11       Impact factor: 9.941
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.